| Year |
Citation |
Score |
| 2014 |
Gupta K, Brady T, Dyer BM, Malani N, Hwang Y, Male F, Nolte RT, Wang L, Velthuisen E, Jeffrey J, Van Duyne GD, Bushman FD. Allosteric inhibition of human immunodeficiency virus integrase: late block during viral replication and abnormal multimerization involving specific protein domains. The Journal of Biological Chemistry. 289: 20477-88. PMID 24904063 DOI: 10.1074/Jbc.M114.551119 |
0.371 |
|
| 2013 |
Li X, Burnight ER, Cooney AL, Malani N, Brady T, Sander JD, Staber J, Wheelan SJ, Joung JK, McCray PB, Bushman FD, Sinn PL, Craig NL. piggyBac transposase tools for genome engineering. Proceedings of the National Academy of Sciences of the United States of America. 110: E2279-87. PMID 23723351 DOI: 10.1073/Pnas.1305987110 |
0.679 |
|
| 2013 |
Zhong L, Malani N, Li M, Brady T, Xie J, Bell P, Li S, Jones H, Wilson JM, Flotte TR, Bushman FD, Gao G. Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correction. Human Gene Therapy. 24: 520-5. PMID 23621841 DOI: 10.1089/Hum.2012.112 |
0.35 |
|
| 2013 |
Brady T, Kelly BJ, Male F, Roth S, Bailey A, Malani N, Gijsbers R, O'Doherty U, Bushman FD. Quantitation of HIV DNA integration: effects of differential integration site distributions on Alu-PCR assays. Journal of Virological Methods. 189: 53-7. PMID 23348058 DOI: 10.1016/J.Jviromet.2013.01.004 |
0.388 |
|
| 2012 |
Pace MJ, Graf EH, Agosto LM, Mexas AM, Male F, Brady T, Bushman FD, O'Doherty U. Directly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latency. Plos Pathogens. 8: e1002818. PMID 22911005 DOI: 10.1371/Journal.Ppat.1002818 |
0.312 |
|
| 2012 |
Scholler J, Brady TL, Binder-Scholl G, Hwang WT, Plesa G, Hege KM, Vogel AN, Kalos M, Riley JL, Deeks SG, Mitsuyasu RT, Bernstein WB, Aronson NE, Levine BL, Bushman FD, et al. Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells. Science Translational Medicine. 4: 132ra53. PMID 22553251 DOI: 10.1126/Scitranslmed.3003761 |
0.313 |
|
| 2012 |
Bushman FD, Brady T, Malani N, Leboulch P, Hacein-Bey S, Cavazzana-Calvo M, Ocwieja K, Roth S, Berry CC. 134 HIV DNA Integration Jaids Journal of Acquired Immune Deficiency Syndromes. 59: 55. DOI: 10.1097/01.Qai.0000413753.07879.71 |
0.325 |
|
| 2011 |
Schaller T, Ocwieja KE, Rasaiyaah J, Price AJ, Brady TL, Roth SL, Hué S, Fletcher AJ, Lee K, KewalRamani VN, Noursadeghi M, Jenner RG, James LC, Bushman FD, Towers GJ. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency Plos Pathogens. 7. PMID 22174692 DOI: 10.1371/Journal.Ppat.1002439 |
0.402 |
|
| 2011 |
Brady T, Bushman FD. Nondividing cells: a safer bet for integrating vectors? Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 640-1. PMID 21455211 DOI: 10.1038/Mt.2011.40 |
0.371 |
|
| 2011 |
Ocwieja KE, Brady TL, Ronen K, Huegel A, Roth SL, Schaller T, James LC, Towers GJ, Young JA, Chanda SK, König R, Malani N, Berry CC, Bushman FD. HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. Plos Pathogens. 7: e1001313. PMID 21423673 DOI: 10.1371/Journal.Ppat.1001313 |
0.45 |
|
| 2011 |
Brady T, Roth SL, Malani N, Wang GP, Berry CC, Leboulch P, Hacein-Bey-Abina S, Cavazzana-Calvo M, Papapetrou EP, Sadelain M, Savilahti H, Bushman FD. A method to sequence and quantify DNA integration for monitoring outcome in gene therapy. Nucleic Acids Research. 39: e72. PMID 21415009 DOI: 10.1093/Nar/Gkr140 |
0.419 |
|
| 2011 |
Ronen K, Negre O, Roth S, Colomb C, Malani N, Denaro M, Brady T, Fusil F, Gillet-Legrand B, Hehir K, Beuzard Y, Leboulch P, Down JD, Payen E, Bushman FD. Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat β-thalassemia. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1273-86. PMID 21386821 DOI: 10.1038/Mt.2011.20 |
0.399 |
|
| 2009 |
Brady T, Agosto LM, Malani N, Berry CC, O'Doherty U, Bushman F. HIV integration site distributions in resting and activated CD4+ T cells infected in culture. Aids (London, England). 23: 1461-71. PMID 19550285 DOI: 10.1097/Qad.0B013E32832Caf28 |
0.428 |
|
| 2009 |
Brady T, Lee YN, Ronen K, Malani N, Berry CC, Bieniasz PD, Bushman FD. Integration target site selection by a resurrected human endogenous retrovirus. Genes & Development. 23: 633-42. PMID 19270161 DOI: 10.1101/Gad.1762309 |
0.459 |
|
| 2009 |
Ciuffi A, Ronen K, Brady T, Malani N, Wang G, Berry CC, Bushman FD. Methods for integration site distribution analyses in animal cell genomes. Methods (San Diego, Calif.). 47: 261-8. PMID 19038346 DOI: 10.1016/J.Ymeth.2008.10.028 |
0.447 |
|
| 2008 |
Brady TL, Schmidt CL, Voytas DF. Targeting integration of the Saccharomyces Ty5 retrotransposon. Methods in Molecular Biology (Clifton, N.J.). 435: 153-63. PMID 18370074 DOI: 10.1007/978-1-59745-232-8_11 |
0.685 |
|
| 2008 |
Brady TL, Fuerst PG, Dick RA, Schmidt C, Voytas DF. Retrotransposon target site selection by imitation of a cellular protein. Molecular and Cellular Biology. 28: 1230-9. PMID 18086891 DOI: 10.1128/Mcb.01502-07 |
0.673 |
|
| 2007 |
Dai J, Xie W, Brady TL, Gao J, Voytas DF. Phosphorylation regulates integration of the yeast Ty5 retrotransposon into heterochromatin. Molecular Cell. 27: 289-99. PMID 17643377 DOI: 10.1016/J.Molcel.2007.06.010 |
0.539 |
|
| Show low-probability matches. |